The Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti‐<scp>TNF</scp> Therapy: A Multicentre StudyJeffrey D. McCurdy, Siddharth Singh, Talal Alenezi et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 12
Outcomes of a mandatory non-medical switch of infliximab to a biosimilar for inflammatory bowel disease in British Columbia, CanadaT T Hoang, Greg Rosenfeld, Jacqueline Reid et al.|Journal of the Canadian Association of Gastroenterology|2024Cited by 5
Su1762 A CLINICAL/RADIOLOGIC RISK ASSESSMENT MODEL CAN ACCURATELY PREDICT PERIANAL FISTULA HEALING IN PATIENTS WITH CROHN'S DISEASE: A MULTICENTER COHORT STUDYJeffrey D. McCurdy, D. Blair Macdonald, Javeria Munir et al.|Gastroenterology|2023Cited by 0
Su1717 THE IMPACT OF EXAMINATIONS UNDER ANESTHESIA AND SETONS ON FISTULA HEALING IN PATIENTS WITH PERIANAL CROHN'S DISEASE: A MULTICENTER COHORT STUDYJeffrey D. McCurdy, Siddharth Singh, Javeria Munir et al.|Gastroenterology|2023Cited by 0
124: THE IMPACT OF SETONS ON PERIANAL FISTULA OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH ANTI-TNF THERAPY: A MULTICENTER STUDYJeffrey D. McCurdy, Siddharth Singh, Javeria Munir et al.|Gastroenterology|2025Cited by 0